Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Umbra Applied Technologies Group, Inc (OTCMKTS:UATG) Stock On Radar After Agreement with Strategic Capital Partner

Umbra Applied Technologies Group, Inc (OTCMKTS:UATG) on May 19, 2023, announced reaching an agreement with a strategic capital partner for supporting the growth of the subsidiary Ossifix Orthopedics. The private equity firm, which specializes in the medical field, is focused on providing strategic growth capital and works with existing management for increasing sales.

UAT Group Reached Agreement with Strategic Capital Partner

The new partner will be a nine percent stakeholder in Ossifix Orthopedics and give about $2 million in funding capital. The firm will also give additional value such as investors and relationships for including an extensive portfolio of medical facilities, surgeons, and knowledgebase. This will assist Ossifix to expand sales and marketing base.

Chief Financial Officer, Thomas Crom said that though it lowers ownership in Ossifix, it will augment the company’s capability to move ahead without any dilution to UATG’s shareholders. Crom added that the transaction shows the creative ways UATG can fund subsidiaries without diluting the present shareholders. The CFO added that the funding is complex as well as time-consuming but shows Ossifix’s intrinsic value is recognized.

UAT Group Chairman, Alex Umbra said that UAT Group stands is willing to support all the subsidiaries for capitalizing on values created together. Umbra added that the new relationship will both give strategic capital but will also support growth objectives to bolster shareholder value as well as streamline balance sheet debt.

Published by Ian Leigh

Ian Leigh is a specialist in analyzing stocks, SEC and OTC filings, and financials of public and privately-held companies. He has played a significant role in M&A activity, consulting with publicly-held firms on acquisitions and divestitures. He also consults on valuations and branding. He lectures at major universities and teaches at specialty financial schools.